Novartis Gets CDSCO Panel Nod To Study Crizanlizumab Dr. Divya Colin18 Aug 2022 6:00 PM ISTNew Delhi: Pharmaceutical major Novartis has got a green signal from the Subject Expert Committee (SEC) functional under the Central Drugs Standard...
Sun Pharma Gets CDSCO Panel Nod To Study Elagolix 150 mg For Endometriosis Dr. Divya Colin15 Aug 2022 12:30 PM ISTNew Delhi: Denying the request to conduct Phase III study of Elagolix 200mg Tablets with test arm 2, the Subject Expert Committee (SEC) functional...
Synokem gets CDSCO Panel nod to market Topiroxosatat Dr. Divya Colin4 Aug 2022 6:00 PM ISTNew Delhi: Pharmaceutical major Synokem Pharmaceutical has got a green signal from the Subject Expert Committee (SEC) functional under the Central...
Intas Pharma Gets CDSCO Panel Okay To Study Human Normal Immunoglobulin Dr. Divya Colin25 July 2022 6:00 PM ISTNew Delhi: Pharmaceutical major Intas Pharma has got the go-head from the Subject Expert Committee (SEC) functional under Central Drug Standard...
Novartis Ruxolitinib Gets CDSCO Panel Okay for Acute and Chronic Graft Versus Host Disease Dr. Divya Colin22 July 2022 6:00 PM ISTNew Delhi: In response to the pharma major Novartis proposal for additional indication of Ruxolitinib Tablets 5/10/15/20 mg, the Subject Expert...
CDSCO panel rejects Optimus Pharma Phase III CT protocol of Tofacitinib Ointment for androgenic alopecia Dr. Divya Colin20 July 2022 6:00 PM ISTNew Delhi: Citing that there is no scientific rationality data and supportive published literature, the Subject Expert Committee (SEC) functional...
Sanofi gets CDSCO Panel okay to study Dupilumab Dr. Divya Colin19 July 2022 6:00 PM ISTNew Delhi: Directing to include all Serious Adverse Events (SAEs) and adverse events (AEs) of test drug in the informed consent document, the Subject...
Mylan Gets CDSCO Panel Nod To Study COPD drug Revefenacin inhalation solution Dr. Divya Colin18 July 2022 6:00 PM ISTNew Delhi: Pharmaceutical major, Mylan Pharmaceutical has got the go-ahead from the Subject Expert Committee (SEC) functional under Central Drug...
CDSCO panel nod to Roche anti cancer drug Atezolizumab for metastatic triple negative breast cancer Dr. Divya Colin14 July 2022 6:00 PM ISTNew Delhi: Based on the justification provided by the pharmaceutical giant Roche, the Subject Expert Committee (SEC) functional under Central Drug...
Alkem Labs secures CDSCO panel nod to conduct BE study of anti epileptic drug Farhat Nasim1 July 2022 6:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization (CDSCO) recommended for grant of permission...
Exemption from warning label need for marketing dried Ivy leaf extract cough syrup: CDSCO Panel Dr. Divya Colin15 Jun 2022 6:00 PM ISTNew Delhi: Analyzing the details of the concentration of saponin in the drug major USV's Dried lvy Leaf Extract Cough Syrup, the Subject Expert...
Glenmark Gets CDSCO panel nod to market asthma, COPD drug Dr. Divya Colin14 Jun 2022 6:30 PM ISTNew Delhi: Granting the waiver of bioequivalence study, the Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization...
